BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puchner A, Gröchenig HP, Sautner J, Helmy-Bader Y, Juch H, Reinisch S, Högenauer C, Koch R, Hermann J, Studnicka-Benke A, Weger W, Puchner R, Dejaco C. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.Wien Klin Wochenschr. 2019;131:29-44. [PMID: 30643992 DOI: 10.1007/s00508-019-1448-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Ciplea AI, Langer-Gould A, de Vries A, Schaap T, Thiel S, Ringelstein M, Gold R, Hellwig K. Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 2020;7:e723. [PMID: 32327455 DOI: 10.1212/NXI.0000000000000723] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
2 Anderson PO, Momper JD. Clinical lactation studies and the role of pharmacokinetic modeling and simulation in predicting drug exposures in breastfed infants. J Pharmacokinet Pharmacodyn 2020;47:295-304. [PMID: 32034606 DOI: 10.1007/s10928-020-09676-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
3 Daham N, AlMuqrin A, Madani A, AlSaif F. Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report. Biologics 2020;14:127-9. [PMID: 33204064 DOI: 10.2147/BTT.S273762] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Khong EWC, Chan HHL, Watson SL, Lim LL. Pregnancy and the eye. Curr Opin Ophthalmol 2021;32:527-35. [PMID: 34605446 DOI: 10.1097/ICU.0000000000000778] [Reference Citation Analysis]
5 Honap S, Meade S, Ibraheim H, Irving PM, Jones MP, Samaan MA. Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Dig Dis Sci 2021. [PMID: 33723700 DOI: 10.1007/s10620-021-06932-4] [Reference Citation Analysis]
6 Romanowska-Próchnicka K, Felis-Giemza A, Olesińska M, Wojdasiewicz P, Paradowska-Gorycka A, Szukiewicz D. The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding. Int J Mol Sci 2021;22:2922. [PMID: 33805757 DOI: 10.3390/ijms22062922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ciplea AI, Hellwig K. Exposure to natalizumab during pregnancy and lactation is safe - Commentary. Mult Scler 2020;26:892-3. [PMID: 32508210 DOI: 10.1177/1352458520928795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Proschmann U, Haase R, Inojosa H, Akgün K, Ziemssen T. Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation. Front Immunol 2021;12:715195. [PMID: 34512637 DOI: 10.3389/fimmu.2021.715195] [Reference Citation Analysis]
9 Rong JM, Luo J, Huang Q, Miao YL. Individualized selection of biological agents in treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2021; 29(15): 893-900 [DOI: 10.11569/wcjd.v29.i15.893] [Reference Citation Analysis]
10 Collier EK, Seivright JR, Shi VY, Hsiao JL. Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety. Dermatol Ther 2021;34:e14674. [PMID: 33320387 DOI: 10.1111/dth.14674] [Reference Citation Analysis]
11 Mouyis M. Postnatal Care of Woman with Rheumatic Diseases. Adv Ther 2020;37:3723-31. [PMID: 32729009 DOI: 10.1007/s12325-020-01448-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Pervez H, Usman N, Ahmed MM, Hashmi MS. The Impact of Inflammatory Bowel Disease on Pregnancy and the Fetus: A Literature Review. Cureus 2019;11:e5648. [PMID: 31700750 DOI: 10.7759/cureus.5648] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Raine T, Gkini MA, Irving PM, Kaul A, Korendowych E, Laws P, Foulkes AC. Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists. BioDrugs 2021;35:187-99. [PMID: 33635522 DOI: 10.1007/s40259-020-00464-5] [Reference Citation Analysis]
14 Fernández-Sánchez M, Ribes-Artero H, Romá-Sánchez E, Gómez-Portero MR, Guerrero-Hurtado E, García-Pellicer J, Poveda-Andrés JL. Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report. Birth Defects Res 2021. [PMID: 34309233 DOI: 10.1002/bdr2.1942] [Reference Citation Analysis]
15 Lamberg T, Sipponen T, Valtanen S, Eklund KK, Mälkönen T, Aalto K, Mikola K, Kolho KL, Leinonen S, Isomäki P, Mäkinen H, Vidqvist KL, Kokko A, Huilaja L, Kyllönen M, Keskitalo P, Sard S, Vähäsalo P, Koskela R, Kröger L, Lahtinen P, Haapala AM, Korkatti K, Sokka-Isler T, Jokiranta TS; BLING Research Group. Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases. Autoimmunity 2022;:1-10. [PMID: 35481450 DOI: 10.1080/08916934.2022.2067985] [Reference Citation Analysis]
16 Zöllkau J, Hagenbeck C, Hecher K, Pecks U, Schlembach D, Simon A, Schlösser R, Schleußner E. [Recommendations for SARS-CoV-2/COVID-19 during Pregnancy, Birth and Childbed - Update November 2021 (Long Version)]. Z Geburtshilfe Neonatol 2021. [PMID: 34918334 DOI: 10.1055/a-1688-9398] [Reference Citation Analysis]
17 Bonek K, Roszkowski L, Massalska M, Maslinski W, Ciechomska M. Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment. Cells 2021;10:323. [PMID: 33557301 DOI: 10.3390/cells10020323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ciplea AI, Datta P, Rewers-Felkins K, Baker T, Gold R, Hale TW, Hellwig K. Dimethyl fumarate transfer into human milk. Ther Adv Neurol Disord 2020;13:1756286420968414. [PMID: 33193814 DOI: 10.1177/1756286420968414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Agrawal H, Doan H, Pham B, Khosla A, Babu M, McCluskey P, Nguyen QD, Sangwan V, Reddy S, Sawhney S, Tyagi M. Systemic immunosuppressive therapies for uveitis in developing countries. Indian J Ophthalmol 2020;68:1852-62. [PMID: 32823402 DOI: 10.4103/ijo.IJO_1548_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Campanati A, Diotallevi F, Martina E, Paolinelli M, Radi G, Offidani A. Safety update of etanercept treatment for moderate to severe plaque psoriasis. Expert Opin Drug Saf 2020;19:439-48. [PMID: 32178543 DOI: 10.1080/14740338.2020.1740204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Saito J, Yakuwa N, Takai C, Kaneko K, Goto M, Nakajima K, Yamatani A, Murashima A. Abatacept concentrations in maternal serum and breast milk during breastfeeding and an infant safety assessment: a case study. Rheumatology (Oxford) 2019;58:1692-4. [PMID: 31323087 DOI: 10.1093/rheumatology/kez135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
23 De Lorenzo R, Ramirez GA, Punzo D, Lorioli L, Rovelli R, Canti V, Barera G, Rovere-Querini P. Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives. Pharmacol Res 2020;152:104583. [PMID: 31816434 DOI: 10.1016/j.phrs.2019.104583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Collier EK, Price KN, Grogan T, Fernandez JM, Seivright JR, Alhusayen R, Alavi A, Hamzavi IH, Lowes MA, Porter MJ, Shi VY, Hsiao JL. Provider perspectives on the management of hidradenitis suppurativa in pregnancy - A survey study. Int J Womens Dermatol 2021;7:346-8. [PMID: 34222596 DOI: 10.1016/j.ijwd.2020.12.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]